that stakeholders are involved in this preliminary phase to foster a culture of compliance across the organization.

Step 2: Facility Design and Layout

When designing the facility, it is crucial to ensure that the layout aligns with GMP regulations to facilitate efficient operations while minimizing contamination risks. The facility should be designed to prevent cross-contamination between different manufacturing processes, particularly if the facility is used for both veterinary and OTC products.

Key considerations during the facility design phase include:

• Separation of production areas for different types of products
• Controlled access to sensitive areas
• Material and personnel flow to minimize contamination
• Designated areas for quality control testing and stability testing for veterinary products

Using simulation and layout software can help visualize workflows and identify potential issues before construction. Additionally, ensure compliance with relevant standards, including WHO GMP and other applicable regulations.

Step 3: Risk Assessment for Shared Facilities

Conducting a risk assessment is a critical step when operating shared facilities, particularly in organizations that produce both veterinary and OTC products. The objective is to identify potential hazards that could compromise product integrity and develop mitigation strategies.

Implement the following steps in your risk assessment process:

• Identify potential risks associated with shared equipment and spaces.
• Assess the likelihood and potential impact of each risk.
• Prioritize risks based on their severity and develop corresponding control measures.
• Document all findings, including the rationale for decisions made during the assessment.

Tools such as Failure Mode and Effects Analysis (FMEA) and Hazard Analysis and Critical Control Points (HACCP) can effectively guide this process. Keep all records up-to-date and ensure that staff are trained to recognize and mitigate risks continuously.

Step 4: Equipment Qualification and Validation

Equipment used in shared facilities must undergo rigorous qualification and validation processes. This step is essential to demonstrate that all equipment functions correctly and meets specified standards consistently.

The qualification process should involve:

• Design Qualification (DQ): Verify that the equipment design meets the operational and regulatory specifications.
• Installation Qualification (IQ): Confirm that the equipment is installed correctly and is operational in an environment that meets regulatory requirements.
• Operational Qualification (OQ): Test the equipment under defined conditions to ensure it operates correctly across all specified parameters.
• Performance Qualification (PQ): Validate that the equipment consistently performs according to its intended use in real-world scenarios.

Document all qualification steps thoroughly, including validation protocols and summary reports, to provide regulators and inspectors with clear evidence of compliance.

Step 5: Developing SOPs and Documentation Control

Standard Operating Procedures (SOPs) are essential in ensuring consistent and compliant operations within shared facilities. Each SOP should detail specific processes related to manufacturing, quality control, cleaning, and maintenance in compliance with Schedule M.

To develop effective SOPs:

• Identify critical operations that require SOPs and prioritize according to risk.
• Draft SOPs that include objectives, materials required, procedures, responsibilities, and any related reference documents.
• Implement a review and approval process for SOPs to ensure that all relevant stakeholders validate the content.
• Establish a document control system to manage revisions and ensure that outdated versions are replaced or archived correctly.

All SOPs must be easily accessible to staff and included in training programs to ensure compliance and competency in executing the procedures.

Step 6: Validation of Cleaning Processes

For manufacturers operating shared facilities, cleaning validation is critical to prevent cross-contamination between veterinary and OTC products. Establishing robust cleaning protocols and validating their effectiveness ensures regulatory compliance and product safety.

The cleaning validation process involves the following steps:

• Develop cleaning procedures for shared equipment and areas, specifying cleaning agents and methods.
• Establish acceptance criteria based on residue limits, which should be compliant with applicable regulations.
• Conduct validation studies, including visual inspections and recovery studies, to demonstrate that cleaning processes effectively remove residues.
• Document all validation results, including detailed protocols, outcome reports, and relevant certificates of analysis.

Maintain a vigilant cleaning schedule and regularly reassess cleaning protocols against current regulatory standards and best practices. Ensure that all staff involved in cleaning activities are trained adequately.

Step 7: Quality Control Laboratories

A critical component of any manufacturing operation is the quality control (QC) laboratory, which should be designed to facilitate testing of raw materials, in-process materials, and finished products. When shared facilities are employed, it becomes crucial to manage workflows and prevent contamination effectively.

Consider the following aspects when setting up or optimizing QC laboratories:

• Design separate workspaces, equipment, and storage areas to avoid contamination risk.
• Implement strict protocols for sample handling and analysis to ensure validity and reliability of results.
• Incorporate stability testing for veterinary products into the laboratory’s capabilities, addressing required shelf-life studies and efficacy assessments.
• Maintain clear documentation on QC methodologies and results to ensure transparency and compliance during inspections.

Regular audits of laboratory performance and compliance with international standards will help maintain readiness for regulatory inspections, ensuring that all laboratory activities meet Schedule M and other applicable guidelines.

Step 8: Training and Competency Assessment

The final step in implementing a robust risk management approach in shared facilities is ensuring that staff is adequately trained and assessed for competency in GMP practices. Training is not just a regulatory requirement; it is essential in promoting an organizational culture that values quality and compliance.

To structure an effective training program:

• Identify training needs across different roles related to manufacturing, quality control, and maintenance.
• Develop a comprehensive training curriculum that covers all aspects of GMP, including specific Schedule M requirements relevant to your facility.
• Conduct training sessions regularly, utilizing a mix of theoretical and practical modules to enhance understanding and retention.
• Implement competency assessments to evaluate the effectiveness of training programs and identify areas for further development.

Document all training activities, including attendance records, training materials, and assessment outcomes, ensuring they are readily available for inspections and audits.